DOI: 10.1055/s-00000025

Hormone and Metabolic Research

References

Farquharson CAJ, Struthers AD.
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. 
Circulation 2000; 101: 594-597  

Download Bibliographical Data

Search in:
Access: